ISL
NEPH icon

Ingalls & Snyder LLC’s Nephros NEPH Stock Holding History

Ingalls & Snyder LLC’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-133,140
Closed -$839K – 428
2020
Q1 		$839K Sell
133,140
-1,399
-1% -$11.9K 0.06% 215
2019
Q4 		$1.34M Buy
134,539
+68,750
+105% +$612K 0.07% 171
2019
Q3 		$530K Buy
+65,789
New +$482K 0.03% 280

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ingalls & Snyder LLC's NEPH Position: Q2 2020 in Review

Ingalls & Snyder LLC sold out of Nephros (NEPH) in Q2 2020, closing a stake of 133,140 shares — an estimated $839K sold.

Ingalls & Snyder LLC first reported a position in NEPH in Q3 2019 and held it in 3 quarters. The position peaked at $1.34M in Q4 2019. 21 funds tracked by Wall St. Rank hold NEPH as of Q2 2020.

  • Ingalls & Snyder LLC reported no remaining Nephros position as of Q2 2020 after selling out during the quarter.
  • Ingalls & Snyder LLC sold 133,140 Nephros shares in Q2 2020, an estimated $839K.
  • Ingalls & Snyder LLC first reported a position in Nephros in Q3 2019 and held it in 3 quarters.
  • Ingalls & Snyder LLC's Nephros position peaked at $1.34M in Q4 2019.
  • 21 funds tracked by Wall St. Rank held Nephros as of Q2 2020.

Based on Ingalls & Snyder LLC's 13F filing for Q2 2020, filed 31 Jul 2020.